Alpha2beta1 integrin in cancer development and chemoresistance

D Naci, K Vuori, F Aoudjit - Seminars in cancer biology, 2015 - Elsevier
Extracellular matrix, via its receptors the integrins, has emerged as a crucial factor in cancer
development. The α2β1 integrin is a major collagen receptor that is widely expressed and …

Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis

M Schlesinger, G Bendas - Cancer and Metastasis Reviews, 2015 - Springer
The integrin “very late antigen-4”(VLA-4) is expressed by numerous cells of hematopoietic
origin and possesses a key function in the cellular immune response, eg, by mediating …

[HTML][HTML] CD49d is the strongest flow cytometry–based predictor of overall survival in chronic lymphocytic leukemia

P Bulian, TD Shanafelt, C Fegan… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Although CD49d is an unfavorable prognostic marker in chronic lymphocytic
leukemia (CLL), definitive validation evidence is lacking. A worldwide multicenter analysis …

[PDF][PDF] Regulación y función de la metaloproteinasa de matriz (MMP-9) en la leucemia linfocítica crónica-B y su papel en la patogénesis de la enfermedad

JR Muñoz - 2010 - core.ac.uk
¡ Ya está! Después de estos años en el laboratorio llego a la meta y puedo dar las gracias a
las personas que me han acompañado en este camino. Espero no dejarme a nadie en el …

High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated …

F Palacios, P Moreno, P Morande… - Blood, The Journal …, 2010 - ashpublications.org
Interaction of chronic lymphocytic leukemia (CLL) B cells with tissue microenvironment has
been suggested to favor disease progression by promoting malignant B-cell growth …

The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells

A Zucchetto, T Vaisitti, D Benedetti, E Tissino… - Leukemia, 2012 - nature.com
CD49d and CD38 are independent negative prognostic markers in chronic lymphocytic
leukemia (CLL). Their associated expression marks a disease subset with a highly …

[HTML][HTML] Cell trafficking in chronic lymphocytic leukemia

MS Davids, JA Burger - Open journal of hematology, 2012 - ncbi.nlm.nih.gov
Chronic lymphocytic leukemia (CLL) is an indolent lymphoproliferative disorder
characterized by both circulating peripheral disease as well as involvement of the lymph …

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia

G Brachtl, J Piñón Hofbauer, R Greil, TN Hartmann - Annals of hematology, 2014 - Springer
The interactions of chronic lymphocytic leukemia cells with the microenvironment in
secondary lymphoid tissues and the bone marrow are known to promote CLL cell survival …

An updated perspective on current prognostic and predictive biomarkers in chronic lymphocytic leukemia in the context of chemoimmunotherapy and novel targeted …

JA Cohen, R Bomben, F Pozzo, E Tissino, A Härzschel… - Cancers, 2020 - mdpi.com
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a variable clinical
course. Novel biomarkers discovered over the past 20 years have revolutionized the way …

[图书][B] Flow cytometry of hematological malignancies

C Ortolani - 2021 - books.google.com
Flow Cytometry of Hematological Malignancies Flow cytometric analysis is often integral to
the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow …